| Document Date: 2005-10-13 09:14:57
Open Document File Size: 72,31 KBShare Result on Facebook
Company Immunotope Inc. / / Country United States / / Event FDA Phase / / Facility Duke University / Jefferson Center / Duke University Cancer Center / Major Histocompatibility Complex / / IndustryTerm treatment of other forms of cancer / biotechnology / treatment of cancer / immunoproteomics technologies / immunotherapy products / / MedicalCondition residual tumor / tumor / ovarian cancer / early stage cancer / cancer / chronic infectious diseases / metastasis / solid tumors / melanoma / different ovarian tumor / / MedicalTreatment chemotherapy / surgery / immunotherapy / / Organization Duke University / US Food and Drug Administration / Duke University Cancer Center / Jefferson Center for Biomedical Research / / Person Ramila Philip / / Position President / Major / / Product Investigational New Drug / OCPM / / ProvinceOrState Indiana / / Technology immunotherapeutics / biotechnology / chemotherapy / immunoproteomics technologies / /
SocialTag |
Immunotope OCPM Vaccine to be Evaluated in Phase I Ovarian Cancer Immunotherapy Clinical Trial Trial to evaluate safety and immune response to multi-antigen immunotherapeutic vaccine DOYLESTOWN PA (August 19, [removed]Immu